Showing results (751-760 of 1,188) with videos related to

Sort By:
Pageof 119
Investigational New Drugs|May 3, 2015
Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignanciesGuillermo Garcia-Manero, Raoul Tibes, Tapan Kadia, et al.
Molecular Cancer Therapeutics|March 9, 2017
Focal Adhesion Kinase as a Potential Target in AML and MDSBing Z Carter, Po Yee Mak, Xiangmeng Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2021
Clinical Outcomes of Patients With Chronic Myeloid Leukemia With Concurrent Core Binding Factor Rearrangement and Philadelphia ChromosomeKiyomi Morita, Elias Jabbour, Farhad Ravandi, et al.
Leukemia|November 14, 2019
Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromesGuillermo Montalban-Bravo, Caleb A Class, Irene Ganan-Gomez, et al.
American Journal of Hematology|December 9, 2017
Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignanciesCourtney D DiNardo, Caitlin R Rausch, Christopher Benton, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2020
Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid LeukemiaFarhad Ravandi, Sherry Pierce, Guillermo Garcia-Manero, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 13, 2019
Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid LeukemiaAbhishek Maiti, Kiran Naqvi, Tapan M Kadia, et al.
Clinical Nephrology|March 22, 2021
Rectus abdominis muscle thickness as a predictor of peritoneal catheter dysfunction in emergency-start peritoneal dialysis patientsJonathan S Chávez-Iñiguez, Pablo Maggiani-Aguilera, José A Cruz-Ramos, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2014
A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemiaAlfonso Quintás-Cardama, Naval Daver, Hawk Kim, et al.
Pageof 119